markets.financialcontent.com Β·
stockstory 2026 5 7 the 5 most interesting analyst questions from select medicals q1 earnings call
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedSelect Medical's Q1 earnings show revenue beat but margin compression due to higher outpatient rehab costs and lower Medicare Advantage conversion rates. The commercial mechanism is margin squeeze from input cost pressure (labor, clinic closures) and reimbursement headwinds. Impact is single-company/supply-chain-specific, not global or sector-wide. No direct commodity or supply scarcity.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources β not direct quotes from the publisher.
- Select Medical Q1 2026 revenue $1.42B vs estimate $1.41B, +5% YoY
- Profit margin fell to 6.9% from 8.3% YoY
- Closure of four Oregon clinics cost ~$1M
- Full-year revenue guidance reaffirmed at $5.7B
- Midpoint EPS guidance reaffirmed at $1.27
Select Medical's outpatient rehabilitation services may see a 0-50bps margin compression in the mid-term; impact expected in 2-4 weeks.
Sign in to see all sector verdicts, full thesis and counter-argument debate.